SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form DEF 14A - Other definitive proxy statements:
SEC Accession No. 0001140361-19-015162
Filing Date
2019-08-16
Accepted
2019-08-15 17:37:08
Documents
4
Period of Report
2019-09-24
Effectiveness Date
2019-08-16

Document Format Files

Seq Description Document Type Size
1 DEF 14A nc10004088x1_def14a.htm DEF 14A 1101264
2 logo_pds.jpg GRAPHIC 27786
3 nc10004088x1_proxy01.jpg GRAPHIC 1130188
4 nc10004088x1_proxy02.jpg GRAPHIC 828759
  Complete submission text file 0001140361-19-015162.txt   3645260
Mailing Address 300 CONNELL DRIVE SUITE 4000 BERKELEY HEIGHTS NJ 07922
Business Address 300 CONNELL DRIVE SUITE 4000 BERKELEY HEIGHTS NJ 07922 800-208-3343
PDS Biotechnology Corp (Filer) CIK: 0001472091 (see all company filings)

IRS No.: 264231384 | State of Incorp.: DE | Fiscal Year End: 1231
Type: DEF 14A | Act: 34 | File No.: 001-37568 | Film No.: 191031173
SIC: 2834 Pharmaceutical Preparations